BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Prognosis
7 results:

  • 1. Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: a experimental single-arm phase II clinical trial pilot study.
    Zheng C; Liu Y; Wang X; Bi Z; Qiu P; Qiao G; Bi X; Shi Z; Zhang Z; Chen P; Sun X; Wang C; Zhu S; Meng X; Song Y; Qi Y; Li L; Luo N; Wang Y
    Int J Surg; 2024 Mar; 110(3):1527-1536. PubMed ID: 38116673
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer Cells Promote Immune Regulatory Function of Macrophages by Upregulating Scavenger Receptor MARCO Expression.
    Gu C; Wiest M; Zhang W; Halder K; Zurawski S; Zurawski G; Joo H; Oh S
    J Immunol; 2023 Jul; 211(1):57-70. PubMed ID: 37212598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients.
    Wu M; Lu L; Dai T; Li A; Yu Y; Li Y; Xu Z; Chen Y
    Cancer Biomark; 2023; 36(1):83-96. PubMed ID: 36591654
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exploration of the immune microenvironment of breast cancer in large population cohorts.
    Deng Y; Wang J; Hu Z; Cai Y; Xu Y; Xu K
    Front Endocrinol (Lausanne); 2022; 13():955630. PubMed ID: 36046784
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Machine Learning Model to Predict the Triple Negative breast cancer Immune Subtype.
    Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
    Front Immunol; 2021; 12():749459. PubMed ID: 34603338
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single-cell profiling defines the prognostic benefit of CD39
    Losurdo A; Scirgolea C; Alvisi G; Brummelman J; Errico V; Di Tommaso L; Pilipow K; Colombo FS; Fernandes B; Peano C; Testori A; Tinterri C; Roncalli M; Santoro A; Mazza EMC; Lugli E
    Commun Biol; 2021 Sep; 4(1):1117. PubMed ID: 34552178
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
    Wang X; Hu B; Shen H; Zhou H; Xue X; Chen Y; Chen S; Han Y; Yuan B; Zhao H; Zhi Q; Kuang Y
    Biomed Pharmacother; 2015 Oct; 75():218-25. PubMed ID: 26271144
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.